Pfizer Inc.

GLP-1. GIP. Amylin. NuSH. What sounds like “alphabet soup” is actually reshaping how researchers understand obesity. New science is revealing how hormones, brain signaling, metabolism, and the gut-brain axis influence weight regulation — and is driving updated approaches to treatment. Read more: on.pfizer.com/4banflc #GLP1 #ObesityScience #Metabolism #Healthcare

For years, Dan Morgan has helped doctors understand the role certain medications can play in cancer care. At age 46, he became a patient. Because he was proactive about prostate cancer screening, doctors caught it early. Now, Dan’s sharing his story. on.pfizer.com/4evVVQH

The first participants have been dosed in VESPER-6 and SOLIS-1, part of 20+ study starts planned across Pfizer's obesity pipeline in 2026. Learn more about our pipeline: pfizer.com/pipeline

Vaccine development is complex, but experience makes the difference. At Pfizer, decades of vaccine innovation are helping our scientists explore new ways to help prevent disease caused by C. difficile infection. Learn more: on.pfizer.com/44azpqn

Pfizer is at #EHA2026 in Stockholm this week presenting 20+ abstracts across blood cancers, sickle cell disease, and hemophilia — committed to turning breakthroughs into real-world impact for patients and those who love them.

Pfizer is advancing obesity science. New Phase 2b data for our investigational GLP‑1 RA peptide show robust efficacy and favourable GI tolerability across weekly and monthly dosing, supporting our extensive pivotal program. Learn more: [link] #ADASciSessions #Obesity #GLP1 #ClinicalTrials #Innovation #Healthcare

Not all migraine attacks are random. Hormonal shifts during your menstrual cycle can trigger longer attacks with more severe symptoms. Understanding the science can help you anticipate triggers and explore ways to address symptoms. on.pfizer.com/49IpbAY #MigraineRelief #HormoneHealth#WomensHealth

At #ADASciSessions this weekend, new Phase 2b data from our obesity pipeline will feature at a late-breaking expert symposium. At Pfizer we’re working to advance treatment approaches intended to address the many needs of people living with obesity and related comorbidities. Learn more about this important area of research: on.pfizer.com/4x5k1ZT #Obesity #ClinicalTrials #Innovation #Healthcare

What does progress look like for people living with a rare form of lung cancer? Read about the evolving science that is shifting the treatment landscape for patients like David. nytimes.com/paidpost/pfize…

Ask people living with cancer what matters most. The answer is almost always the same: more time with the people they love. Hear from Pfizer scientists ahead of #ASCO26

What does it mean to bring science to life? Hear from Pfizer scientists doing it every day. #ASCO26

As the sixth most common cancer in the U.S., bladder cancer demands our attention. Recognize potential symptoms and learn when to start the conversation this #BladderCancerAwarenessMonth: @LetsTalkBladderCancer/shorts" target="_blank" rel="nofollow noopener">youtube.com/@LetsTalkBladd…

For Pfizer scientist Shuo, cancer research isn’t just a job—it’s personal. A close friend’s diagnosis shaped how she sees her work and why it matters. Today, she shows up in the lab every day to help move cancer research forward. #CancerResearchMonth Read her story: on.pfizer.com/4uVbW8J

What’s the third most common cancer diagnosed in the U.S.? Lung cancer. And it’s not just smokers: Up to 20% of cases occur in people who’ve never smoked. Know the risks. Understand the myths. Read more: on.pfizer.com/4dP4x38 #LungCancer

Cancer isn’t slowing down – so science can’t either. As #ASCO26 gets underway, discover how Pfizer is working to bring science from the lab to life in our latest @TIME feature: time.com/branded-conten…

At Pfizer, colleagues like Jennifer embody the essence of what it takes to be a scientist: deep expertise, a genuine passion for discovery, and a commitment to helping people around the world. Learn more about the kind of work scientists like Jennifer do every day: on.pfizer.com/3RkxbSn

Clinical trials rely on researchers, clinicians, site teams, and volunteers all working toward the same goal: helping bring new treatments to patients. This #ClinicalTrialsDay, #ResearchRising recognizes the collective effort behind every step of the process. Learn more: on.pfizer.com/3PPMgec

Lyme disease impacts people of all ages with 70% of tick exposures occurring during routine outdoor activities close to home. This #LymeDiseaseAwarenessMonth, we’re drawing the line to help you learn about daily risk and prevention options: on.pfizer.com/4df7sCb

The @EU_Commission has approved our once-weekly treatment option for people with #hemophilia A or B with inhibitors. This milestone reflects our continued commitment to advancing care for people living with hemophilia. Learn more: on.pfizer.com/4dGp1w8

Our new state-of-the-art Oncology R&D campus in San Diego, California is officially open - purpose built to bring oncology science to life and accelerate discoveries that turn breakthroughs into impact for patients. Learn more: on.pfizer.com/4d7rvng